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Control of the immune response by genes in the H-2 complex (Ir genes) has 
been investigated in thymic-dependent antigen systems involving synthetic poly- 
peptides and complex protein antigens (1-4). The study of such antigens led to 
the conclusion that only those immune responses which require significant T  cell 
contribution would exhibit Ir gene control (5). As a result, little is known about 
the Ir gene regulation of relatively T-independent antigens. 
The ability to elicit an immune response to relatively T-independent type 2 
antigens  in  nude  mice suggested that  the  response  to  these antigens did  not 
require  T  cell  cooperation  (6).  In  experiments using  T  cell  lines and  T  cell 
hybrids,  however,  the  immune response  to  optimal  concentrations of type  2 
antigens could be eliminated by T  cell depletion and reconstituted with purified 
T  cells or T  cell-derived supernatant factors (7, 8).  In addition, studies of the 
response to type 2 antigens also implicated a strict dependence on macrophages 
bearing major histocompatibility complex (MHC) ~  class lI molecules (Ia antigens) 
(9-11). These observations indicated that the immune response to type 2 antigens 
shared many essential characteristics with conventional Ir gene-controlled sys- 
tems  and  suggested  that  their  immune response  was  under  genetic  control. 
Control of type 2 responses, however, also appear to involve mechanisms differ- 
ent than those controlling the response to classic T-dependent antigens. 
We have studied the genetic regulation of a  typical type 2 antigen, trinitro- 
phenyl  (TNP)-Ficoll,  and  have  reported  that  the  primary  in  vitro  antibody 
response was regulated by two distinct loci (12).  One locus of control mapped to 
the I-A  subregion  as  determined by  both  recombinant analysis and  blocking 
studies  with  I-A  subregion-specific monoclonal antibodies.  The  second  locus 
mapped in or to the right of the I-E subregion, as determined by recombinant 
analysis and blocking  with  a  broadly specific alloantiserum produced in  mice 
differing at the/-E, S, and D regions. 
In this report,  we demonstrate by recombinant analysis that the right-hand 
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locus of immune response control is located between the H-2S and D regions. In 
addition, a monoclonal antibody directed against this right-hand region of control 
has been produced (48-21.7) that blocks the response to TNP-Ficoll at the level 
of the antigen-presenting cell. The monoclonal antibody 48-21.7  is specific for 
the high responder b allele at the right-hand locus and does not inhibit responses 
to  other protein  antigens  tested.  The  immune  response  to  TNP-Ficoll  is  not 
inhibited by monoclonal antibodies  that  react with H-2D  b or Qa-2  specificities, 
suggesting that the TNP-Ficoll response is controlled by a  unique locus located 
between  H-2S  and  D.  Finally,  48-21.7  recognizes  and  precipitates  an  unique 
product  of  ~40,000  mol  wt  that  is  distinct  from  the  H-2D  b region  product 
recognized by the monoclonai antibody B22/249. 
Materials and Methods 
Mice.  All mice were bred in our colony at the University of Michigan and used when 
2-6 mo old. Original breeders were obtained from The Jackson Laboratory, Bar Harbor, 
ME and from Dr. Donald Shreffler, Washington University, St. Louis, MO. 
Antigens.  TNP-aminoethyl  carbamethyl  (AECM)-Ficoll  (conjugation  ratio,  TNP34- 
AECM-FicolI),  was obtained from Biosearch Laboratories, San Rafael, CA.  TNP-bovine 
gamma globulin (TNP-BGG) was purchased from Calbiochem-Behring Corp., San Diego, 
CA, and contained 61 TNP groups per molecule of BGG. 
Antisera.  Restricted anti-Ia alloantisera were prepared as previously described (13- 
15). Batches of serum from several bleedings were tested in a dye exclusion microcytotox- 
icity assay for appropriate anti-Ia reactivity and antibody titer (15).  The hybridoma cell 
lines  MKD6  (anti-I-A  a)  and  MKS4  (anti-I-A  s)  were  gifts  from  Dr.  Phillippa  Marrack, 
National Jewish  Hospital, Denver, CO.  The cell line producing monoclonal antibodies 
directed against specificity Ia. 17 (10-2.16) was obtained from the Salk Cell  Distribution 
Center, La Jolla, CA. Monoclonal antibody Y-7KB (anti-Qa-2  a) was a gift from Dr. Donal 
Murphy, Yale University, New Haven, CT. 
Cell  Culture  Conditions.  Single-cell suspensions of individual spleens were prepared 
and seeded at 4 x  106 lymphocytes per well (four wells per condition) in Mishell-Dutton 
culture medium (16) with  10%  fetal calf serum (FCS) (Reheis Co.  Inc., Phoenix, AZ). 
Cultures were established in  24-well  plates (Costar,  Data Packaging Corp., Cambridge, 
MA).  Antigen was added at a  final concentration of 0.1  #g/ml TNP-Ficoll or 5 #g/ml 
TNP-BGG in a final volume of 1 ml/well. Plates were incubated for 4 d at 37°C in 7% 
CO> 
For experiments requiring purified cell preparations, separation of the cells was accom- 
plished using previously published procedures (17, 18). Briefly, for peritoneal macrophage 
isolation,  mice were  injected intraperitoneally with  45  /~g of concanavalin A  (Con  A) 
(Pharmacia Fine Chemicals, Piscataway, NJ) in 1.5 ml phosphate-buffered saline (PBS). 3 
d  later, peritoneal exudate cells  were harvested by flushing the peritoneum with cold 
tissue  culture  medium  containing  0.1  M  Hepes  and  10%  FCS.  Cells  were  pelleted, 
resuspended, and the number of viable cells determined. These cells have been demon- 
strated to be ~70% Ia  + macrophages. Purified macrophages were seeded in 24-well Costar 
plates at the desired number of Ia  ÷ macrophages; usually 5% of the number of macro- 
phage-depleted cells  were added per  well.  The cells  were allowed to adhere for 2  h, 
washed to remove nonadherent cells, treated with mitomycin C (Sigma Chemical Co., St. 
Louis, MO), and extensively washed.  In antibody pretreatment experiments, 0.5  ml of 
appropriately diluted antibody was added per well; macrophages were then incubated for 
45 min and washed four times with fresh medium. 
Macrophage-depleted spleen cells were prepared by repeated incubation of cells with 
carbonyl  iron  powder  (Atomergic  Chemetals  Corp.,  Plainview,  NY)  and  removal  of 
phagocytic cells  with  a  strong  magnet.  Cells  incorporating latex particles and  having 
morphologic characteristics of macrophages comprised <1% of this remaining cell popu- HILLSTROM  SHAPIRO  ET  AL.  1479 
lation. Total cell loss with this procedure was 40-50%, but no difference in the T  cell/B 
cell ratio could be discerned. 
Controls for each experiment included: macrophage-depleted spleen cells plus antigen; 
untreated  macrophages plus antigen;  and  macrophages pretreated with  antibody plus 
antigen. These controls produced no plaque-forming cells (PFC) in any experiment. 
Local Hemolysis in Gel.  TNP-specific, IgM antibody-producing cells were assayed on 
day 4 of the culture period by a modified Jerne technique (19, 20).  Sheep erythrocytes 
were lightly conjugated with TNP and used to determine the number of direct PFC (21). 
Greater than 90% of PFC were inhibited by 10  -2 M TNP-lysine. Results were corrected 
for background PFC using nohaptenated sheep erythrocytes. 
Production  of Antibody-secreting Hybrid Cell Lines.  6-8-wk-old female B10.A(3R) mice 
were initially injected with 2 x  107 lymphoid cells from C57BL/6 mice both intraperito- 
neally and subcutaneously,  followed  1 wk  later by an  intravenous injection.  After six 
injections, the mice were bled and the serum tested for activity. 3 d after the last injection, 
when the serum had the desired activity, the mice were boosted and the immune spleen 
cells were fused with P3X63-Ag8.653 myleoma cells (22-24). 
Fine  Specificity  Testing.  Clones  that  were  positive  for  antibody  production  were 
screened for their ability to block the in vitro primary antibody response to TNP-Ficoll 
in  the high  responder D2.GD strain.  Positive clones were subcioned twice by limiting 
dilution  and  tested  for  maximum  inhibitory  capacity.  Supernatants  from  expanding 
cultures were collected, processed, and stored at -20°C. In addition, high titer antibody 
was produced by inducing ascites tumors in [BALB/c X B10.A(3R)]F1  mice primed with 
pristane  (2,6,10,14-tetramethylpentadecane,  96%)  (Aldrich  Chemical  Co.,  Milwaukee, 
WI). Monoclonal antibody 48.21, an IgM class antibody, was purified by Sephacryl S-300 
gel  filtration  of the  40%  ammonium  sulfate  fraction  of ascites.  Purity  of the  IgM 
preparation was determined by SDS-PAGE. 
Radiolabeling  and Precipitation  of Antigens.  The procedures for radiolabeling mouse 
spleen lymphocytes and for extracting and immunoprecipitation of antigens are modifi- 
cations of those described by Jones (25).  Briefly, splenic lymphocytes were incubated for 
4-5 h at 25 x  10  6 cells/ml in methionine-free RPMI  1640 medium containing 5% FCS 
and 250 ~Ci/ml  [35S]methionine/ml (1,000 mCi/mmol; New England  Nuclear, Boston, 
MA). Membrane proteins were extracted from washed cells with 0.5% Nonidet P-40 (Bio- 
Rad Laboratories, Richmond, CA) buffer. Immune complexes were removed from lysates 
by centrifugation at  15,000 g  for  15  min and incubation for 3  h  with Staphylococcus 
protein A-coupled Sepharose beads (Staph A beads) (Pharmacia Fine Chemicals, Pisca- 
taway, N  J). 
Antigens were immunoprecipitated from the extracts with either supernatants  from 
antibody-producing hybridomas  or  purified ascites.  Lysates  were  incubated  with  the 
antibody overnight, followed by the addition of Staph A beads or, for IgM antibodies, 
Staph A beads complexed with rabbit anti-mouse IgM, A, and G (Accurate Chemical & 
Scientific Co., Westbury, NY).  The bound proteins were eluted from the Staph A with 
electrophoresis buffer containing sodium dodecyl sulfate (SDS) (Bio-Rad Laboratories) 
and 2-mercaptoethanol (2-ME) (Aldrich Chemical Co.) for reducing gels or without 2-ME 
for nonreducing analysis. 
SDS-PAGE Analysis.  Precipitated proteins were separated in 12% SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) gels according to standard procedures. Separating gels 
contained  12%  acrylamide (Bio-Rad  Laboratories) with  0.5%  N,N-diallyltartardiamide 
(DATD) crosslinker and  0.1%  SDS.  Stacking gels contained 4% acrylamide; 25  ~1 vol 
protein samples were added to each lane and gels were electrophoresed at 25 mA/gel. 
They were then fixed in 30% methanol,  10% acetic acid, 10% TCA; enhanced in  1.0 M 
sodium salicylate, dried, and autoradiographed for 4 d at -70°C. 
Results 
We have previously reported (12) that the primary immune response to TNP- 
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complex. The first locus was found to map within the I-A subregion and required 
the d and s alleles for the high  responder and the k allele for the intermediate 
responder phenotype. A second region of control was defined in or to the right 
of the I-E subregion with b or s as the high  responder alleles. The presence of 
high responder alleles at both loci was required for maximum response to TNP- 
Ficoll. Finally, high responses obtained in complementing (low responder x  low 
responder)Fl hybrid animals confirmed the dual locus regulation of the response, 
and demonstrated that these distinct loci complement in the trans as well as the 
cis configuration. 
Analysis of responses of recombinant strains B 10.S(7R) and B 10.A(2R) allowed 
a  more  precise  definition  of  the  right-hand  locus  of  control  (Fig.  1).  The 
B10.S(7R) strain (K', IS, S', D d) is identical to the high responder B10.S (K', I', S', 
D') strain with the exception of the low responder d allele at the H-2D region.  If 
the right-hand  locus controlling  the TNP-Ficoll response mapped  within  the I 
region, the B 10.S(7R) recombinant would produce a response equivalent to that 
of the  B10.S strain.  Challenge  of B10.S(7R)  recombinant  strain,  however,  re- 
sulted in  significantly  lower numbers  of TNP-specific plaques per culture and 
implicated an area of control outside of the I region, very close to or within the 
H-2D region. 
The response of the B10.A(2R) (K  k, I k, S d, O b) strain  was assayed in an effort 
to  determine  the  role  of  the  H-2D  locus  in  the  TNP-Ficoll  response.  This 
recombinant is identical to the low responder B10.A strain but expressed a high 
responder b allele at H-2D.  If the right-hand  locus of control mapped in H-2D, 
the B10.A(2R) recombinant would produce a response equivalent to the (B10.A 
X BI0)FI  (K  k/b, I k/b,  S d/b,  Dd/b), (520 _  90 PFC/culture) that  expresses the same 
alleles at the relevant  loci. Challenge  of the B10.A(2R) strain  resulted in a  low 
response equivalent  to that  of the  B10.A parental  strain.  This result indicated 
that  the  crossover in  the  B10.A(2R) recombinant  occurred to the right  of the 
gene controlling the TNP-Ficol] response, and, consequently, these mice fail to 
express  the  high  responder  b  allele  at  the  right-hand  locus.  Therefore,  the 
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FIGURE  1.  Assay of recombinant strains with crossover events occurring between the H-2S 
and D regions. Quadruplicate wells of 4  x  106 normal spleen cells were challenged with 0.1 
#g/ml TNP-Ficoll and assayed on day 4 for TNP-specific IgM PFC. Responses of each strain 
were normalized to the high responder D2.GD response of 1,000 PFC/culture. HILLSTROM  SHAPIRO  ET  AL.  1481 
responses of the B.10S(7R)  and B10.A(2R)  strains suggest a  locus of immune 
response control located between the S and D regions, bounded on the left by 
the  crossover  event  in  the  B10.S(7R)  recombinant  and  on  the  right  by  the 
crossover event in the B10.A(2R) strain. 
Because the strains mapping the right-hand locus of control were of different 
haplotype combinations, it was possible that the differences in response observed 
between the  B10.S(7R)  and the  B10.A(2R)  strains were due to differences in 
genetic  organization  of the  two  haplotypes (s  vs.  a)  rather  than  differences 
introduced by recombination. To eliminate this possibility, three congenic strains 
(developed by Dr. Shreffler, Washington University, St. Louis, MO) with recom- 
bination occurring between the H-2S and H-2D regions were studied. Each of 
these strains was  independently derived from a  (B10  X B10.A) parental cross 
and  identified as  a  recombinant  by  serological  analysis  (26).  The  results  of 
challenging these strains with TNP-Ficoll and the control antigen TNP-BGG are 
shown in Table I. The I-A  k, S/D  b combination of alleles produced an intermediate 
response of ~500  PFC/culture in response  to TNP-FicolI, a  level of response 
observed in the B10.A(4R) and (B10 x  B10.A)F1  strains. 
The combination of I-A k, S/D  ~ resulted in a low responder phenotype as seen 
in  the  B10.A  (Fig.  1)  and  B10.A(2R)  strains (140  +  36  and  190  +  36  PFC/ 
culture, respectively). Thus, if the recombination in a strain had occurred to the 
right of the gene controlling the response to TNP-Ficoll, the strain would express 
low  responder  alleles  at  both  loci,  and  resulted  in  a  response  equivalent  to 
B10.A(2R) mice. Alternatively, if the crossover in the particular strain occurred 
to the left of this gene, the strain would express the high responder b allele at 
this right-hand locus and show an intermediate response equivalent to B 10.A(4R) 
mice. 
Challenge of the new recombinant strains produced the results shown in Table 
I. Each of the strains produced equivalent responses to the control antigen TNP- 
BGG. The B10.BAR11 and B10.BAR6 strains produced low responses to TNP- 
Ficoll, indicating indentity with the B10.A(2R) strain at the right-hand locus, in 
contrast,  the  B10.BAR10  strain  showed  intermediate responses,  like  that  of 
B10.A(4R)  mice.  Therefore,  comparison  of  responses  in  the  B10.BAR6, 
TABLE  | 
Comparison of Antibody Responses to TNP-Ficoll in Strains with Crossovers Between the 
H-2S and H-2D Regions 
Strain  K  I-A/I-E  S  D  TNP-Ficoll*  TNP-BGG 
B10.BAR6  k  k/k  d  b  148 _  32  240 ___ 63 
B10.BAR10  k  k/k  d  b  425 +_  191  320 +  70 
B10.BAR11  k  k/k  d  b  110 --- 36  275 +  75 
B10.A(2R)  k  k/k  d  b  190 _  36  ND 
B10.A(4R)  k  k/b  b  b  512 +  140  380 +  163 
(B10 x  B10.A)F~  b  b/b  b  b  502 +  91  279 +  86 
k  k/k  d  d 
* Results are expressed as PFC/culture of four pooled wells of 4 x  106 spleen cells. In each experiment 
at least three mice from each strain were tested. Data of four experiments are normalized to a high 
responder D2/GD response of 1,000 PFC/culture.  ND, not done. 1482  CHARACTERIZATION  OF  AN  Ir  LOCUS BETWEEN H-2S AND D 
B 10.BAR 10, and B 10.BAR 11 strains defined a locus controlling the response to 
TNP-Ficoll in a single haplotype, bounded on the left by the crossover event in 
the B10.BAR10 and on the right by the crossover event in the B10.BAR6 and 
B10.BAR11 strains. 
Antibody  Blocking  of the  Response  to  TNP-Ficoll.  Previous  studies  (I 2)  have 
demonstrated  that  the response to TNP-Ficoll is significantly inhibited  by pre- 
treatment  of complementing  (low responder  ×  low responder)F~  macrophages 
with  antiserum  directed  toward  high  responder  determinants  of either  locus, 
while antibodies directed toward the corresponding low responder determinants 
have no effect. These results indicated that antibodies directed toward specific 
determinants  could  be  used  in  functional  assays to  identify  those  cell  surface 
antigens directly involved in controlling the response to TNP-Ficoll. To confirm 
the recombinant analysis of the TNP-Ficoll response and to investigate the role 
of the  H-2D  region  in  its  control,  antibody blocking studies  were performed. 
Con A-induced peritoneal  exudate cells were used as a source of macrophages 
in  these  experiments.  These  cells  were  purified  and  pretreated  with  either 
alloantiserum  or monoclonal  antibodies and  mitomycin  C,  washed extensively, 
and  cultured  with  syngeneic carbonyl  iron-treated  spleen  cells and  antigen  as 
described in Materials and Methods. 
Initial  blocking experiments showed that both alloantiserum  and monoclonal 
antibodies directed  against  high  responder  I-A  specificities effectively blocked 
the  response  to TNP-Ficoll.  Blocking of the  right-hand  region  of control  was 
demonstrated by inhibition of the response with the broadly specific B10.A(3R) 
anti-C57BL/6 alloantiserum,  which contained antibodies directed against mem- 
brane-expressed  gene  products  of the I-E through  H-2D  segment  of the  high 
responder  b  haplotype  (Fig.  2).  The  anti-D b activity of this  antisera  could  be 
absorbed with EL-4 cells that bear class I but not class II molecules. Absorption 
of anti-D b activity was confirmed by cytotoxic tests (data not shown). As shown 
in  Fig.  2,  the  ability  of this  antiserum  to  block  the  TNP-Ficoll  response  is 
unaffected by removal of anti-D b activity. 
To produce a specific probe to the right-hand  locus of control,  spleens from 
mice  producing  the  B10.A(3R) anti-C57BL/6  alloantiserum  (anti-Eb-D b)  were 
fused  with  the  P3X63Ag8.653  myeloma  (22).  Antibodies  produced  by  the 
resulting hybridomas were screened for their ability to block the D2.GD response 
to  TNP-Ficoll.  The  results  of  the  screening  of  two  different  subclones  of 
monoclonal antibody 48-21  are shown in  Fig.  3.  Pretreatment  of macrophages 
with antibodies from either  48-21.7 or 48-21.4 subclones resulted in inhibition 
equivalent to that obtained with B10.A(3R) anti-C57BL/6 alloantiserum. 
Further  characterization  of the  specificity of monoclonal  antibody  48-21.7 
included assessment of its effect on responses to other antigens.  Fig. 4 illustrates 
that  48-21.7  did  not  alter  the  primary  antibody  responses  of high  responder 
D2.GD animals  to the  T-dependent  antigen  TNP-BGG.  Pretreatment  of mac- 
rophages  with  48-21.7  blocked  the  TNP-Ficoll  response  by  62%,  yet  with 
identical  pretreatment  it had  no effect on the primary response to TNP-BGG. 
In addition, pretreatment of macrophages with 48-21.7 had no effect on second- 
ary responses to either  LDH-B or MOPC-173 as measured in the T  cell prolif- H1LLSTROM  SHAP1RO  ET  AL.  1483 
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FIGURE 2.  Antibody blocking of the primary response to TNP-FicolI.  D2GD macrophages 
were pretreated with antibodies appropriate for the I-A subregion products (MKD6), alloserum 
specific for I-E through  H-2D regions (unabsorbed); serum with H-2D specificities removed 
(absorbed); or inappropriate monoclonal antibodies (14-4-4S). 
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FIGURE 3.  Primary in vitro antibody response to TNP-Ficoll when Con A-induced D2.GD 
peritoneal macrophages are briefly pretreated with two different subclones of the hybridoma 
48-21. Macrophages were purified and incubated with medium, inappropriate anti-I-A  s anti- 
bodies (MKS4), appropriate anti-l-A  d (MKD6), alloantiserum B10.A(3R) anti-C57BL/6, super- 
natant of subclone 48-21.4, and 48-21.7.4 x  106 macrophage-depleted cells and antigen were 
added. On day 4, TNP-specific plaques were determined on a pooled sample of three cultures. 
eration assay (data not shown). These results strongly suggest that the monoclonal 
antibody 48-21.7 recognized a specificity unique to the TNP-Ficoll response. 
Similarly,  Fig.  5  illustrates  that  blocking  by 48-21.7  was haplotype  specific. 
High responder B 10.S (K s, I s, S s, D s) macrophages were purified and pretreated 
with the inappropriate anti-I-A ~ (MKD6) antibodies, or the appropriate anti-I-A s 
(MKS4) antibodies.  Test antisera  were the B10.A(3R) anti-C57BL/6 alloantise- 
rum,  which recognizes the right-hand  region of the b haplotype, or monoclonal 
antibody 48-21.7. The inability of the 48-21.7 monoclonal antibody to block the 
TNP-Ficoll  response  in  the  high  responder  s  haplotype  indicated  that  allelic 
forms of the high responder determinant  may exist. 
In  an  effort to  rule  out  an  H-2D  region  contribution  to  the  control  of the 
response to TNP-FicoII, D2.GD macrophages were pretreated with a monoclonal 
antibody  (B22/249)  that  specifically recognized  the  class  I  determinant  H-2D b 1484  CHARACTERIZATION OF  AN  lr  LOCUS  BETWEEN  H-2S  AND D 
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(27,  28).  Fig.  6  illustrates  that macrophage pretreatment  with  monoclonal anti- 
body  B22/249  had  no  effect  on  the  response  to TNP-FicolI.  In  addition,  this 
result indicates that binding of the antibody B22/249 to the D2.GD macrophage 
cell  surface,  as demonstrated  by cytotoxic tests,  is not sufficient  to inhibit  their 
ability to generate a  TNP-Ficoll  PFC response. 
It has  been  suggested  (29)  that quantitative  variation  in  the amount  of Qa-1 HILLSTROM  SHAPIRO  ET  AL.  1485 
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antibodies, appropriate anti-l-A  d (MKD6) antibodies, 48-21.7,  or H-2Db-specific monoclonal 
antibody  B22/249,  washed,  and  cultured  with  4  x  106  syngeneic  T-B  cells  and  antigen. 
Cultures of three pooled wells were assayed on day 4. 
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FIGURE 7.  Anti-Qa-2"-specific monoclonal antibodies do not block the primary response to 
TNP-Ficoll.  D2.GD  macrophages  were  purified,  pretreated  with  inappropriate  anti-I-A  s 
(MKS4) antibodies, appropriate anti-l-A  d (MKD6) antibodies, 48-21.7, or Qa-2"-specific mon- 
oclonal antibody Y-7KB, washed, and cultured with 4  ×  106 syngeneic T-B cells and antigen. 
Cultures of three pooled wells were assayed on day 4. 
antigen expressed on the cell surface is controlled by a gene within or very close 
to H-2D. Qa-2 expression has been postulated to be controlled by a similar gene 
in an analogous manner (30). This hypothesis raised the question whether control 
of the TNP-Ficoll  response  by the right-hand  locus was mediated through  the 
quantitative expression of a Qa antigen rather than the qualitative expression of 
a  unique  molecule.  To test this  possibility,  macrophages  were pretreated  with 
monocional antibodies specific for a Qa-2 region-controlled determinant,  Y-7KB 
(Fig.  7).  Qa-2  is  the  predominant  Qa  antigen  found  on  cells  other  than  T 
[ymphocytes (31), If 48.21  either recognized a Qa-2 molecule or the product of 
the gene which regulated the quantitative expression of Qa-2, then Y-7KB should 
produce results similar to those obtained with 48-21.7.  The failure of the anti- 
Qa-2  reagent  to  inhibit  the  TNP-Ficoll  response  demonstrated  that  the  Qa-2 1486  CHARACTERIZATION  OF  AN  Ir  LOCUS BETWEEN H-2S AND  D 
specificity recognized by  this  antibody  was  not  involved in  the  response,  and 
supported the conclusion that 48-21.7  recognized a  unique specificity encoded 
between S and D. 
Characterization  of the Product Recognized  by 48-21.7.  Initial characterization 
of the product recognized by the monoclonal antibody 48-21.7 by immunopre- 
cipitation  of endogenously  [3~S]methionine-labeled  whole  spleen  lysates  from 
D2.GD is shown in Fig. 8.  12% SDS-PAGE analysis resolved a product of 40,000 
(40  K)  mol  wt  precipitated by the  monoclonal antibody 48-21.7.  This band  is 
slightly smaller than the band precipitated with the anti-H-2D  b monoclonal B22/ 
249. To determine whether 48.21  and B22/249 could be recognizing different 
forms of the same molecule, sequential  immunoprecipitations were performed. 
As can be seen  from Fig.  8b,  when  D2.GD splenic  lysates were cleared of any 
material  reactive  with  B22/249  and  then  tested  for  the  presence  of material 
reactive with  48-21,  the  40  K  mol  wt  band  was  observed (lane B).  When  the 
reverse was done, that is,  when  lysates were cleared of 48-21-reacting  material 
and the resulting cleared lysate was precipitated with B22/249,  a  43  K  tool wt 
FIGURE 8.  (a)  D2.GD  immunoprecipitates in reducing 12% SDS-PAGE. D2.GD splenic cell 
lysates (A)  immunoprecipitated with inappropriate antibody anti-I-A  s (MKS4), (B) immuno- 
precipitated  with 48.21.7,  (C)  immunoprecipitated  with B22/249  (H-2Db). (b)  Sequential 
immunoprecipitates of D2.GD splenic lysates with 48-21.7 and  B22/249  in reducing  12% 
SDS-PAGE. (A)  First precipitation with B22.249, second precipitation with the same B22/ 
249  antibody.  (B)  First precipitation  with B22/249,  second precipitation  with 48.21.7. 
(C)  First  precipitation with 48.21.7, second precipitation with 48.21.7. (D)  First  precipitation 
with 48.21.7, second precipitation with B22/249. HILLSTROM  SHAPIRO  ET  AL.  1487 
band  was observed (Fig.  8b,  lane D).  Control  lanes A  and  C  demonstrate  the 
completeness of removal of B22/249-(A)  and  48.21-(C)  reactive material  from 
the  first precipitation.  These  results  indicate  that  the  molecule recognized by 
48.21  is distinct from the H-2D  b molecule. 
Discussion 
The  experiments  presented  demonstrate  that  the primary  in  vitro antibody 
response to TNP-Ficoll is controlled by two complementing loci.  Recombinant 
analysis mapped  one locus to the I-A subregion, and the second locus between 
the  S  and  D  regions.  Other  investigators  (B2)  have  also  found  evidence  for 
immune response control loci outside of the I  region and close to the D end of 
the  H-2  complex.  Berzofsky et  al.  (2)  showed  that  the  antibody  response  to 
equine myoglobin was controlled by two complementing genes, one in I-A and a 
second  in  tt-2D.  This  conclusion  was  reached  by  recombinant  analysis  and 
confirmed by testing strain tt-2 ~mt, which has a mutation in the H-2D region (B3). 
In addition, a  genetic region between S and D, designated H-2U by O'Neill and 
Parish (B4), was identified by alloantisera produced in strains that differed at the 
D  region.  This  allosera  retained  activity  against  several  target  strains  after 
absorption to remove D-specific antibodies. The H-2U region appears to control 
antigens similar in their cellular distribution and molecular weight to Ia antigens. 
Krco et al. (35) demonstrated that the control of the T  cell proliferative response 
to hemoglobin mapped to two separate Ir genes, one of which mapped to the D 
end of the 1-1-2 complex. Recombinant strains challenged with intact hemoglobin 
or the alpha  subunit demonstrated  I-A  region  control  (BS),  whereas challenge 
with the beta chain subunit exhibited control mapping to the H-2D region. 
In  addition  to  the  evidence placing lr genes between  the  S and  D  regions, 
other  evidence  has  mapped  genes  controlling  the  phenotypic  expression  of 
certain  enzymes  to  the  region  near  the  H-2D.  For  example,  Neu-1,  a  locus 
controlling the activity of the enzyme neuraminidase,  which alters the sialation 
of at  least five different enzymes, has been  closely linked to the D  region  (B6, 
37).  Variants  of these  enzymes  were  originally  thought  to  be  controlled  by 
.separate loci mapping to H-2, but now variants appear to be the result of different 
alleles of the Neu-1 locus (38). It is important to note, however, that the patterns 
of allelic variation of Neu-1 do not follow the patterns of high and low response 
established for the response to TNP-Ficoll. For example, Cfi7BL/10 and BALB/ 
c strains both have the Neu-1 b allele but C57BL/10 carries the TNP-Ficoll high 
responder b haplotype, and BALB/c, the low responder d haplotype. It is unlikely, 
therefore, that the Neu-1 locus is involved in the regulation of the Ficoll response. 
The existence of multiple genes mapping to the right  end of the  MHC, and 
the presence of genes that control or modify the expression of other molecules 
on the cell surface, raised the possibility that the product of the right-hand  locus 
which controls the response to TNP-Ficoll did not function in a manner similar 
to an  Ia  antigen.  In  fact,  the  molecular  weight  of the  product  recognized  by 
monoclonal  antibody 48-21.7  indicated  that  this  could be the case.  The  40  K 
tool wt protein, immunoprecipitated  with 48-21.7, was more similar to that of a 
class  I  or  class  I-related  (Qa,  Tla)  gene  product  than  a  typical  class  II  gene 
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Molecular  data  has  shown  that  the  d  haplotype  contains  36  distinct  class  I 
genes (39).  31  of the  36  class  I  genes have  been  mapped  to  the  Qa  and  Tla 
regions  of the  MHC,  while  the  other  five  map  to  H-2K  and  D  regions  (40). 
Studies of the b haplotype have indicated 23 of 26 class I genes in this haplotype 
to map to the Qa-2,3 and TL regions (41). To date, the function and expression 
of the products of most of these genes is unknown. 
The presence of genes in the region  between H-2S  and  Tla  that control  the 
quantitative expression of the class I-related antigens Qa-1  and, perhaps,  Qa-2, 
has raised the possibility that Qa-1 or Qa-2 were in someway responsible for the 
different  levels  of response  to  TNP-Ficoll  (29,  30).  Quantitative  as  well  as 
qualitative differences in expression of Qa-1  specifities in certain  mouse strains 
have been demonstrated by variations in cytotoxicity and absorption of antiserum 
activity. For example, H-2D k strains express less of the Qa-1  antigen than  other 
strains  (29).  Similarly,  immunochemical  and  serological  studies  demonstrated 
that  different  strains  expressed  varying  amounts  of  the  Qa-2  antigen,  and 
recombinant analysis suggested that  these quantitative  differences were due to 
modifying  genes  located  to  the  right  of the  S  region,  distinct  from  the  Qa 
structural genes (30, 42, 43). In some instances, quantitative variation in expres- 
sion of class I molecules has been shown to influence function. For example, the 
amount of H-2D product on the cell surface correlates with resistance to virus 
infection (44) and with immunity against virus-infected cells (45). However, it is 
unlikely that  Qa or H-2D molecules are involved in regulation  of the immune 
response to TNP-FicolI. 
The strongest evidence against involvement of Qa-2 molecules in the regula- 
tion  of the  TNP-Ficoll  response  was the  failure  of the  anti-Qa-2  monoclonal 
antibody  to  block  the  response.  Of course,  the  failure  of a  single  anti-Qa-2 
antibody to inhibit the response to TNP-Ficoll does not rule out the possibility 
that other Qa molecules play a role. However, if 48.21.7 recognizes either a Qa- 
2 ~ determinant  or the product of the gene, located between H-2D and Tla, that 
regulates the  quantitative  expression  of Qa-2,  then  the  anti-Qa-2 a antibody Y- 
7KB would be expected to block the immune response. 
Experiments  in  which  responding  cells  were  pretreated  with  antibody  and 
complement  demonstrated  that  the  specificity recognized  by 48-21.7  was not 
present  on  a  T  or  B  cell  population  critical  to  the  TNP-Ficoll  response.  In 
contrast, treatment cf the T-B populations with the Y-7KB monoclonal antibody 
(anti-Qa-2 ~')  and  complement  resulted  in  significant  elimination  of those  cells 
necessary for this response (data not shown). Similar results have been reported 
by Kincade et al.  (31)  in  which  a  polyvalent Qa-2 alloantiserum  demonstrated 
the presence of Qa on cells capable of primary immune responses to TNP-Ficoll. 
Taken  together,  the failure of the anti-Qa-2  antibody to block the TNP-Ficoll 
response and  the different tissue distribution  of 48-21.7  and  Y-7KB appear  to 
preclude  the  possibility  that  48-21.7  monoclonal  antibody  recognizes  a  Qa 
specificity. Sequential immunoprecipitation studies with 48.21  and Y-7KB are in 
progess. 
Blocking studies were extended to include monoclonal antibodies specific for 
determinants  on  the  class  I  H-2D b  region  molecule  and  demonstrated  that 
products  of the  H-2D b region  do not  participate  in  the  antibody  response  to HILLSTROM  SHAPIRO  ET  AL.  1489 
TNP-FicoI1. The alloantiserum  containing anti-D  b antibodies showed equivalent 
blocking ability before and after class I specificities were removed by absorption. 
In  addition,  pretreatment  of macrophages with  monoclonal antibody  B22/249 
specific for  H-2D b showed no inhibition  of the  TNP-Ficoll  response.  In  more 
recent  experiments  we  have  used  another  monoclonal  antibody  with  H-2D b 
specificity (28-14-8) with similar result. 
Melino et al. (46), in studies directed at determining the molecular heteroge- 
neity of the H-2D b region, used sequential immunoprecipitations with monoclonal 
antibodies  28-14-8  and  B22/249,  and anti-D b alloantisera.  The  sequential  im- 
munoprecipitations  supported  the  existence  of only  one  gene  product  in  this 
region. Others (47), however, have reported evidence for at least three serolog- 
ically detectable molecules controlled in the H-2D b locus. At the DNA level, only 
one  D b  gene  was identified  in  overlapping  cosmid clones of this  region  (41). 
Thus,  the  failure  to  inhibit  the  response  using  anti-D b  antibodies,  and  the 
precipitation  of two distinct  molecules,  support  the  conclusion  that  the  48.21 
antibody does not recognize a class I H-2D  b molecule. 
Our results are consistent with  the hypothesis that  monoclonal  antibody 48- 
21.7 recognizes the product of a novel class I-related gene that is located between 
the S and D loci. Immunoprecipitation analysis strongly suggests that the product 
recognized by 48-21.7 was distinct from either the class I H-2D b molecule or an 
Ia  molecule.  We  do  not  know  for  certain  whether  the  48.21.7  molecule  is 
associated with/32-microglobulin;  reduced SDS-polyacrylamide gels occasionally 
show a very faint band at  12 K mol wt. Since we have seen variable amounts of 
/32-microglobulin precipitated with our  O b reagents, it is possible that an associa- 
tion between /3,, and  the  48.21.7  molecule occurs but is of lower affinity than 
most class I molecules. The observation that there may be no association of the 
product recognized by 48-21.7 and/32-microglobulin may have functional signif- 
icance. In an earlier study (48), cells transfected with clones of class I genes were 
assayed  for an  increase  in  ~32-microglobulin  as an  indicator  of foreign  class  I 
antigen  expression.  Transfected genes that  did not result in increased levels of 
/~2-microglobulin  were assumed  not to encode class I  gene products.  However, 
not all  of the  class  I  genes identified  by Southern  blot analysis of the  murine 
genome were positive in this assay (48). It is possible that one of the genes which 
does not associate with/32-microglobulin  codes for the unique product precipi- 
tated by 48.21. 
One  possibility  which  cannot  be  excluded  is  that  the  recombinant  analysis 
located a  regulatory gene between S and D  which controls the expression of a 
cell  surface antigen  encoded elsewhere.  In  such  a  model,  the  surface antigen 
would  be  involved  in  the  regulation  of the  response  to  TNP-Ficoll  and  be 
recognized by the monoctonal antibody 48-21.7.  It should be noted, however, 
that  a  regulatory  gene  of this nature  would have to exert its control on allelic 
structural  genes in a  haplotype-specific manner.  While this is possible, no such 
mechanism has been reported (49). 
The  relationship  of the  two  loci  required  for  the  response  to  TNP-Ficoll 
remains unclear.  Blocking experiments indicated that cell surface expression of 
high  responder  alleles of both  loci are  mandatory  for optimum  response.  Im- 
munoprecipitation  analysis  suggested  that  there  was  no  physical  association 1490  CHARACTERIZATION  OF  AN  lr  LOCUS BETWEEN H-2S AND  D 
between the I-A gene product and the product of the right-hand locus because 
antibodies specific for each of these loci precipitated distinct products (data not 
shown). The functional role of each of these molecules is unclear. It is possible 
that  the  1-A  molecule  acts  as  a  traditional  Ia  antigen  recognition  structure 
together with some other type of receptor, membrane-bound enzyme, or another 
surface determinant encoded between the H-2S and D regions. There are several 
instances of interactions between genes of the MHC. In addition to the comple- 
mentation of genes in the I-A and I-E regions for an Ia molecule (50),  there are 
examples of interactions between the H-2D and Qa and Tla  regions leading to 
altered expression of  one of the molecules (29, 30, 51). Since an immune response 
function is  associated with  the  48.21.7  molecule, the  TNP-Ficoll  system may 
prove to be a useful model for studying these interactions. It will be particularly 
interesting to  determine whether the  48.21  locus  corresponds  to  any of the 
cloned genes clustering in this region for which no function or product has yet 
been shown. Further characterization of the 48.21.7 product and its locus is in 
progress. 
Summary 
The primary in vitro antibody response to the type 2 antigen, trinitrophenyl 
(TNP)-Ficoll, is controlled by two complementing loci in the H-2 region of the 
mouse major histocompatibility complex (MHC). High responder alleles at both 
loci are necessary for a high responder phenotype. Previous studies mapped one 
locus of control to the 1-A subregion. In this report we demonstrate by recom- 
binant analysis that the second locus of control is located between the H-2S and 
D  regions.  A  comparison  of responses  in  the  B10.BAR6,  B10.BAR10,  and 
B10.BAR11  strains defined a locus controlling the response to TNP-Ficoll in a 
single haplotype, bounded on the left by the crossover event in the B 10.BAR 10 
and on the right by the crossover event in the B10.BAR6 strain. A monoclonal 
antibody directed against this right-hand region of control has been produced 
(48.21.7)  that  blocks  the  response  to  TNP-Ficoll at  the  level of the  antigen- 
presenting cell.  The  monoclonal antibody 48-21.7  is  specific for the high re- 
sponder b allele at the right-hand locus and did not inhibit responses to other 
protein antigens tested. The imnmne response to TNP-Ficoll was not inhibited 
by monoclonal antibodies that react with H-2D b or Qa-2 specificities,  suggesting 
that the TNP-Ficoll response is controlled by a unique locus located between H- 
2S  and  D.  Finally,  48-21.7  recognizes  and  precipitates  a  unique  product  of 
~40,000 mol wt that is distinct from the H-2D region product recognized by the 
monoclonal antibody B22/249. 
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